Jacobson Pharma バランスシートの健全性
財務の健全性 基準チェック /66
Jacobson Pharmaの総株主資本はHK$2.5B 、総負債はHK$652.4Mで、負債比率は26.6%となります。総資産と総負債はそれぞれHK$3.6BとHK$1.2Bです。 Jacobson Pharmaの EBIT はHK$341.2Mで、利息カバレッジ比率14.2です。現金および短期投資はHK$515.9Mです。
主要情報
26.6%
負債資本比率
HK$652.40m
負債
| インタレスト・カバレッジ・レシオ | 14.2x |
| 現金 | HK$515.90m |
| エクイティ | HK$2.46b |
| 負債合計 | HK$1.15b |
| 総資産 | HK$3.61b |
財務の健全性に関する最新情報
These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well
Jun 20
Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?
Feb 09Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden
Jan 11Recent updates
There's Reason For Concern Over Jacobson Pharma Corporation Limited's (HKG:2633) Massive 27% Price Jump
Nov 22Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now
Aug 21Jacobson Pharma's (HKG:2633) Profits May Not Reveal Underlying Issues
Dec 21Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025
Nov 27These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well
Jun 20Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's
Nov 28Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.0268
Sep 25Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?
Sep 16Jacobson Pharma's (HKG:2633) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 28Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's
Jul 14Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?
Feb 09Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.012
Nov 29Jacobson Pharma (HKG:2633) Is Reducing Its Dividend To HK$0.015
Sep 24Here's Why It's Unlikely That Jacobson Pharma Corporation Limited's (HKG:2633) CEO Will See A Pay Rise This Year
Sep 16Kwing Tong Lam Is The Independent Non-Executive Director of Jacobson Pharma Corporation Limited (HKG:2633) And They Just Picked Up 28% More Shares
Feb 03
A Look At The Fair Value Of Jacobson Pharma Corporation Limited (HKG:2633)
Jan 24Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden
Jan 11Does Jacobson Pharma's (HKG:2633) CEO Salary Compare Well With The Performance Of The Company?
Dec 27Is It Smart To Buy Jacobson Pharma Corporation Limited (HKG:2633) Before It Goes Ex-Dividend?
Dec 12Reflecting on Jacobson Pharma's (HKG:2633) Share Price Returns Over The Last Three Years
Dec 03財務状況分析
短期負債: 2633の 短期資産 ( HK$1.1B ) が 短期負債 ( HK$516.5M ) を超えています。
長期負債: 2633の短期資産 ( HK$1.1B ) が 長期負債 ( HK$634.5M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 2633の 純負債対資本比率 ( 5.6% ) は 満足できる 水準であると考えられます。
負債の削減: 2633の負債対資本比率は、過去 5 年間で54%から26.6%に減少しました。
債務返済能力: 2633の負債は 営業キャッシュフロー によって 十分にカバー されています ( 74.2% )。
インタレストカバレッジ: 2633の負債に対する 利息支払い は EBIT ( 14.2 x coverage) によって 十分にカバーされています。